To investigate the role of up-regulated STIM1 in the development of acquired SR in HCC cells, we used CRISPR/Cas9 technology to knock down STIM1 in Hep3B- and MHCC97H-SR cells. This evidence concerns the gene STIM1 and hepatocellular carcinoma.